Electromed (ELMD) Revenue Growth (1y) (2011 - 2026)
Electromed (ELMD) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 6.08% |
| 10 | Electromed | 325.33 Mn | 308.34 Mn | 14.64 Mn | 18.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.43% |
| Dec 31, 2025 | 16.25% |
| Sep 30, 2025 | 15.13% |
| Jun 30, 2025 | 17.27% |
| Mar 31, 2025 | 13.07% |
| Dec 31, 2024 | 18.74% |
| Sep 30, 2024 | 19.02% |
| Jun 30, 2024 | 8.96% |
| Mar 31, 2024 | 14.94% |
| Dec 31, 2023 | 16.71% |
| Sep 30, 2023 | 15.63% |
| Jun 30, 2023 | 20.79% |
| Mar 31, 2023 | 19.00% |
| Dec 31, 2022 | 14.45% |
| Sep 30, 2022 | 6.57% |
| Jun 30, 2022 | 19.01% |
| Mar 31, 2022 | 15.41% |
| Dec 31, 2021 | 7.92% |
| Sep 30, 2021 | 24.95% |
| Jun 30, 2021 | 37.68% |